Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock (LockA locked padlock) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

HHS.gov
  • About HHS
  • Programs & Services
  • Grants & Contracts
  • Laws & Regulations

Breadcrumb

  1. Home
  2. About
  3. News
  4. HHS Secretary Becerra Issues 564 Declaration to Expand the Availability of Testing for Monkeypox
  • News
  • Blog
  • HHS Live
  • Podcasts
  • Media Guidelines for HHS Employees
FOR IMMEDIATE RELEASE
September 7, 2022
Contact: HHS Press Office
202-690-6343
media@hhs.gov

HHS Secretary Becerra Issues 564 Declaration to Expand the Availability of Testing for Monkeypox

Today, U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra signed a declaration under section 564 of the Federal Food, Drug, and Cosmetic Act to allow the U.S. Food and Drug Administration (FDA) Commissioner to issue emergency use authorizations for in vitro diagnostics to expand the availability of tests for monkeypox. This follows the August 4 declaration of a public health emergency for monkeypox.

“Last month, I declared monkeypox to be a public health emergency to unlock additional tools to signal to the American people that we are using every resource at our disposal to end this outbreak,” said Secretary Becerra. “Today’s action is an important step forward in our monkeypox response by allowing the FDA to facilitate the development of more validated monkeypox tests and expand access to testing.”

Today’s action is the latest step the Biden-Harris Administration has taken to respond to the ongoing spread of the monkeypox virus in the United States. Within two days of the first confirmed case in the U.S., the Administration began making vaccines and treatments available to states and other jurisdictions for free.

Through partnerships with the country’s largest commercial laboratories, testing capacity has increased rapidly to more than 80,000 per week as HHS continues to communicate important public health messages and raise awareness with key stakeholders.

To date, HHS has made nearly 1.1 million vials of the JYNNEOS vaccine available to order and, so far, has shipped more than 772,000 vials.

###
Note: All HHS press releases, fact sheets and other news materials are available at https://www.hhs.gov/news.
Like HHS on Facebook, follow HHS on Twitter @HHSgov, and sign up for HHS Email Updates.
Last revised: September 7, 2022

Sign Up for Email Updates

Receive the latest updates from the Secretary, Blogs, and News Releases

Sign Up

Subscribe to RSS

Receive latest updates

Subscribe to our RSS

Related News Releases

  • Fact Sheet: HHS Provides Resources on Ways Communities Can Stay Protected from Mpox in Advance of Summer Months:

  • Statement From HHS Secretary Becerra on mpox

  • Biden Harris Administration Supports the World Health Organization Renaming of Monkeypox to mpox

Media Inquiries

For general media inquiries, please contact media@hhs.gov.

Content created by Assistant Secretary for Public Affairs (ASPA)
Content last reviewed September 7, 2022
Back to top
  • Contact HHS
  • Careers
  • HHS FAQs
  • Nondiscrimination Notice
  • HHS Archive
  • Accessibility
  • Privacy Policy
  • Viewers & Players
  • Budget/Performance
  • Inspector General
  • Web Site Disclaimers
  • EEO/No Fear Act
  • FOIA
  • The White House
  • USA.gov

Sign Up for Email Updates

Receive the latest updates from the Secretary, Blogs, and News Releases.

Sign Up
HHS Logo

HHS Headquarters

200 Independence Avenue, S.W.
Washington, D.C. 20201
Toll Free Call Center: 1-877-696-6775​